$Moderna, Inc.(MRNA)$ , the global mRNA giant, has partnered with artificial intelligence (AI) company OpenAI to embed GPT across all aspects of the company's business, including legal, research, manufacturing, and commercialization.But in this AI frenzy, collaborations between life sciences and AI often blur the lines between reality and hype. Let's dive deeper and see what's really cooking.The partnership kicked off in 2023 with the launch of mChat, powered by OpenAI's API. So far, 80% of Moderna's employees are already using ChatGPT's iterations. They've even got over 750 customized GPTs running on their internal ecosystem. One notable example is the Dose ID GPT, helping researchers pinpoint the right vaccine dose for clinical trials.Selecting